Proposed changes by India’s non-life insurers to require retail health policyholders to share hospital bills could significantly alter the landscape of healthcare costs, subject to regulatory approval and industry debate.
India’s non-life insurers are weighing a proposal that would require retail health policyholders to share part of their hospital bills, a change that could reshape how much families pay out of pocket when they are admitted for treatment. According to The Times of India, the plan under discussion would ask customers to pay 10% of admissible inpatient hospitalisation costs, with the policyholder’s share capped at Rs 5 lakh per claim, from 1 January 2027. The stated aim is to bring down annual premiums, while the wider package also includes common hospital empanelment and a formal dispute-resolution process between insurers and hospitals.
If adopted, the move would mark a significant shift for people who currently assume that cashless treatment means the insurer covers the full bill. Under the proposal described by TV9 Hindi, a patient with a Rs 5 lakh hospital bill would pay Rs 50,000 themselves, while the insurer would settle the balance. The same basic structure would apply whether the claim is processed as cashless or through reimbursement, although the cap is intended to limit a customer’s maximum liability on any one claim.
The idea also reflects a broader co-payment model already familiar in parts of the insurance market. Industry guides note that co-payment clauses are common in some senior-citizen and lower-premium plans, where a policyholder pays a fixed percentage of each claim in exchange for cheaper cover. In this case, insurers appear to be using the same mechanism in an effort to manage rising hospital charges and limit what they view as unnecessary procedures, while promising lower premiums in return.
Even so, the proposal is far from certain. Business Standard reported that the plan would need approval from the Insurance Regulatory and Development Authority of India, and sources quoted by the paper suggested the regulator may be reluctant to clear it. That means policyholders are not facing an imminent change, but the discussion signals continued pressure on the health insurance market as insurers look for ways to control claims costs without pushing premiums even higher.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
